- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Nippon India Pharma Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.81 | 1.91 |
NAV | ₹527.09 | ₹40.13 |
Fund Started | 10 May 2004 | 25 Jun 2018 |
Fund Size | ₹8638.23 Cr | ₹5044.63 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.81
1.91
NAV
₹527.09
₹40.13
Fund Started
10 May 2004
25 Jun 2018
Fund Size
₹8638.23 Cr
₹5044.63 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 33.72% | 47.66% |
3 Year | 18.87% | 24.17% |
5 Year | 28.19% | 31.12% |
1 Year
33.72%
47.66%
3 Year
18.87%
24.17%
5 Year
28.19%
31.12%
Holding Analysis
Equity | 96.97% | 97.27% |
Cash | 3.03% | 2.73% |
Equity
96.97%
97.27%
Cash
3.03%
2.73%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.52% |
Divi's Laboratories Ltd. | 9.65% |
Lupin Ltd. | 7.61% |
Cipla Ltd. | 5.50% |
Apollo Hospitals Enterprise Ltd. | 5.13% |
Dr. Reddy's Laboratories Ltd. | 5.10% |
Vijaya Diagnostic Centre Ltd. | 4.09% |
Ajanta Pharma Ltd. | 3.36% |
Medplus Health Services Ltd. | 3.23% |
Gland Pharma Ltd. | 3.02% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.77% |
Dr. Reddy's Laboratories Ltd. | 8.48% |
Cipla Ltd. | 7.94% |
Aurobindo Pharma Ltd. | 5.04% |
Gland Pharma Ltd. | 4.38% |
Lupin Ltd. | 4.29% |
Alkem Laboratories Ltd. | 4.16% |
Zydus Lifesciences Ltd. | 3.10% |
Apollo Hospitals Enterprise Ltd. | 2.93% |
Biocon Ltd. | 2.39% |
Fund Manager
Name | Akshay Sharma | Dharmesh Kakkad |
Start Date | 01 Dec 2022 | 23 Feb 2021 |
Name
Akshay Sharma
Dharmesh Kakkad
Start Date
01 Dec 2022
23 Feb 2021
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 10 May 2004 | 25 Jun 2018 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 May 2004
25 Jun 2018
